This is behavior change, and Jasper Colins research over the past two years has been tracking it closely
doi:10.1385/JMN:18:1-2:07 47
It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing
Check for drug interactions - Some prescription medicines, like metformin, can deplete B12 over time
Your care team will usually take out your breathing tube while youre still in the operating room
A new double agonist, tirzepatide, marketed as Mounjaro, mimics two, theoretically doubling the strength of the weight-loss effect